Tempramed forms media partnership with Dr. Phil, Envoy

Executive Summary

• Tempramed Technologies Ltd. has entered into a strategic media partnership with Dr. Phil and Envoy Media to accelerate market adoption and brand authority in the United States.
• The agreement includes exclusive title sponsorship of a 44-minute Dr. Phil television special focused on prescription medication safety, scheduled to air in May 2026.
• The partnership provides Tempramed with access to an audience of over 19 million monthly viewers and full content usage rights for long-term monetization across digital, B2B, and international channels.

Key Details

• Partnership Structure: Strategic media partnership between Tempramed Technologies Ltd. and Dr. Phil/Envoy Media.
• Sponsorship Role: Tempramed serves as the exclusive title sponsor of a full-length, 44-minute Dr. Phil-hosted television special.
• Content Focus: The special addresses common and dangerous mistakes regarding prescription medication temperature exposure, positioning Tempramed as the featured solution with no competing brands.
• Air Date: The special is scheduled to air as a Dr. Phil Envoy TV special in May 2026.
• Audience Reach: Access to an audience of over 19 million monthly viewers across broadcast and digital platforms, with a social following exceeding 25 million users.
• Distribution Channels: Multiplatform distribution including broadcast TV, podcasts, YouTube, and social media.
• Content Rights: Tempramed receives full content usage rights to repurpose the special for paid media, digital acquisition, enterprise sales, payer engagement, and international expansion.
• Campaign Strategy: The initiative supports Tempramed's transition from awareness building to scaled demand generation and enterprise engagement.
• Product Integration: The segment includes an on-air interview with a Tempramed spokesperson, integrated calls to action, and persistent on-screen branding.

Notable Quotes

• "Dr. Phil brings unmatched credibility and reach to conversations that matter deeply to patients and families... This partnership allows us to educate millions of people about a largely overlooked risk in medication use -- temperature exposure -- while positioning Tempramed as the clear, trusted solution for medication storage and management. For our investors, this is about accelerating awareness, demand and enterprise engagement at national scale." — Ron Nagar, Chief Executive Officer of Tempramed